الفهرس | Only 14 pages are availabe for public view |
Abstract Patients with a normal karyotype are considered intermediate risk advances in molecular genetic research enabled a better understanding of the mechanisms by which molecular events cause blood malignancies . Techniques such as PCR fluorescence in situ hybridization and comparative genomic hybridization have improved the ability to recognize these molecular lesions |